TCL Archive In Brief CCOP Prospects Submit 130 Letters Of Intent; DeVita recovering On Schedule from Surgery September 26, 1986
TCL Archive In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm January 23, 1998
TCL Archive Intarferon Results Promising, ACS Says, And commits Another $3.4 Million February 22, 1980
TCL Archive “Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate November 7, 1975